Copper balance studies during the treatment of patients with Wilson's disease
- 1 June 1965
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 14 (6) , 653-666
- https://doi.org/10.1016/0026-0495(65)90048-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Tissue copper levels in Chinese patients with Wilson's diseaseNeurology, 1963
- ENVIRONMENTAL TREATMENT OF A HEREDITARY ILLNESS: WILSON'S DISEASEAnnals of Internal Medicine, 1960
- TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINEThe Lancet, 1960
- Penicillamine, a new oral therapy for Wilson's diseaseThe American Journal of Medicine, 1956
- RAPID TEST FOR HEPATOLENTICULAR DEGENERATIONThe Lancet, 1956
- Studies on Copper Metabolism. XIII. Hepatolenticular Degeneration1Journal of Clinical Investigation, 1954
- Deficiency of Ceruloplasmin in Patients with Hepatolenticular Degeneration (Wilson's Disease)Science, 1952
- The Effect of BAL (2,3-Dimercaptopropanol) on Hepatolenticular Degeneration (Wilson's Disease)New England Journal of Medicine, 1951
- THE COPPER AND IRON CONTENT OF BRAIN AND LIVER IN THE NORMAL AND IN HEPATO-LENTICULAR DEGENERATIONBrain, 1948
- Micro-determination of copper in biological materialBiochemical Journal, 1940